Laboratory Exposure to Influenza A H2N2, Germany, 2004–2005
Main Authors: | Annette Schrauder, Brunhilde Schweiger, Udo Buchholz, Walter Haas, Daniel Sagebiel, Adrienne Guignard, Wiebke Hellenbrand |
---|---|
Format: | Article |
Language: | English |
Published: |
Centers for Disease Control and Prevention
2006-12-01
|
Series: | Emerging Infectious Diseases |
Subjects: | |
Online Access: | https://wwwnc.cdc.gov/eid/article/12/12/06-0664_article |
Similar Items
-
Cross-Sectional Study on Influenza Vaccination, Germany, 1999–2000
by: Sybille Rehmet, et al.
Published: (2002-12-01) -
Barriers to pandemic influenza vaccination and uptake of seasonal influenza vaccine in the post-pandemic season in Germany
by: Böhmer Merle M, et al.
Published: (2012-10-01) -
Oseltamivir Prescribing in Pharmacy-Benefits Database, United States, 2004–2005
by: Justin R. Ortiz, et al.
Published: (2008-08-01) -
Influenza A Virus PB1-F2 Gene
by: Roland Zell, et al.
Published: (2006-10-01) -
Low-level Circulation of Enterovirus D68–Associated Acute Respiratory Infections, Germany, 2014
by: Janine Reiche, et al.
Published: (2015-05-01)